{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:21:34Z","timestamp":1790803294463,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T00:00:00Z","timestamp":1735430400000},"content-version":"vor","delay-in-days":242,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/j.jacl.2024.02.003","type":"journal-article","created":{"date-parts":[[2024,2,15]],"date-time":"2024-02-15T00:54:20Z","timestamp":1707958460000},"page":"e430-e443","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Association of Lipoprotein(a) with peri-coronary inflammation in persons with and without HIV infection"],"prefix":"10.1016","volume":"18","author":[{"given":"Erin","family":"Zisman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6236-7201","authenticated-orcid":false,"given":"Mian","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas T.","family":"Funderburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Christenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Jeudy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6857-6207","authenticated-orcid":false,"given":"Shana","family":"Burrowes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison G.","family":"Hays","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nivya","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7690-5258","authenticated-orcid":false,"given":"Michael L.","family":"Freeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0005-9743-8299","authenticated-orcid":false,"given":"Heather","family":"Rebuck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8043-8605","authenticated-orcid":false,"given":"Shashwatee","family":"Bagchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.jacl.2024.02.003_bib0001","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1161\/CIR.0000000000000695","article-title":"Characteristics, prevention, and management of cardiovascular disease in people living with HIV: a scientific statement from the American Heart Association","volume":"140","author":"Feinstein","year":"2019","journal-title":"Circulation."},{"issue":"11","key":"10.1016\/j.jacl.2024.02.003_bib0002","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1161\/CIRCULATIONAHA.117.033369","article-title":"Global burden of atherosclerotic cardiovascular disease in people living with hiv: systematic review and meta-analysis","volume":"138","author":"Shah","year":"2018","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.jacl.2024.02.003_bib0003","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1097\/QAD.0000000000001109","article-title":"Inflammation, immune activation, and cardiovascular disease in HIV","volume":"30","author":"Nou","year":"2016","journal-title":"AIDS"},{"issue":"4","key":"10.1016\/j.jacl.2024.02.003_bib0004","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"issue":"5","key":"10.1016\/j.jacl.2024.02.003_bib0005","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10654-022-00956-4","article-title":"Circulating lipoprotein (a) and all-cause and cause-specific mortality: a systematic review and dose-response meta-analysis","volume":"38","author":"Amiri","year":"2023","journal-title":"Eur J Epidemiol"},{"issue":"1","key":"10.1016\/j.jacl.2024.02.003_bib0006","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1161\/CIRCULATIONAHA.104.517144","article-title":"Early structural and functional changes of the vasculature in HIV-infected children: impact of disease and antiretroviral therapy","volume":"112","author":"Charakida","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacl.2024.02.003_bib0007","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1161\/ATVBAHA.117.309137","article-title":"Lipoprotein(a) and HIV: allele-specific apolipoprotein(a) levels predict carotid intima-media thickness in HIV-infected young women in the women's interagency HIV study","volume":"37","author":"Enkhmaa","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"11","key":"10.1016\/j.jacl.2024.02.003_bib0008","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.024870","article-title":"Lipoprotein(a) and subclinical vascular and valvular calcification on cardiac computed tomography: the atherosclerosis risk in communities study","volume":"11","author":"Obisesan","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"398","key":"10.1016\/j.jacl.2024.02.003_bib0009","doi-asserted-by":"crossref","first-page":"eaal2658","DOI":"10.1126\/scitranslmed.aal2658","article-title":"Detecting human coronary inflammation by imaging perivascular fat","volume":"9","author":"Antonopoulos","year":"2017","journal-title":"Sci Transl Med"},{"issue":"10151","key":"10.1016\/j.jacl.2024.02.003_bib0010","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0140-6736(18)31114-0","article-title":"Non-invasive detection of coronary inflammation using computed tomography and prediction of residual cardiovascular risk (the CRISP CT study): a post-hoc analysis of prospective outcome data","volume":"392","author":"Oikonomou","year":"2018","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.jacl.2024.02.003_bib0011","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/QAD.0000000000003125","article-title":"Assessment of coronary inflammation in antiretroviral treated people with HIV infection and active HIV\/hepatitis C virus co-infection","volume":"36","author":"Jeudy","year":"2022","journal-title":"AIDS"},{"key":"10.1016\/j.jacl.2024.02.003_bib0012","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.116.020838","article-title":"Oxidized phospholipids on lipoprotein(a) elicit arterial wall inflammation and an inflammatory monocyte response in humans","volume":"134","author":"van der Valk","year":"2016","journal-title":"Circulation"},{"issue":"6","key":"10.1016\/j.jacl.2024.02.003_bib0013","first-page":"63","article-title":"The association of lipoprotein (a) and circulating monocyte subsets with severe coronary atherosclerosis","volume":"8","author":"Afanasieva","year":"2021","journal-title":"J Cardiovasc Dev Dis"},{"issue":"4","key":"10.1016\/j.jacl.2024.02.003_bib0014","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.jacl.2015.04.005","article-title":"Monocyte subset distribution in patients with stable atherosclerosis and elevated levels of lipoprotein(a)","volume":"9","author":"Krychtiuk","year":"2015","journal-title":"J Clin Lipidol"},{"issue":"9","key":"10.1016\/j.jacl.2024.02.003_bib0015","doi-asserted-by":"crossref","first-page":"31","DOI":"10.17116\/terarkh201688931-38","article-title":"Lipoprotein(a), its autoantibodies, and circulating T lymphocyte subpopulations as independent risk factors for coronary artery atherosclerosis","volume":"88","author":"Afanasiev\u0430","year":"2016","journal-title":"Terapevticheskii arkhiv"},{"issue":"12","key":"10.1016\/j.jacl.2024.02.003_bib0016","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11883-019-0817-3","article-title":"Perivascular adipose tissue and coronary atherosclerosis: from biology to imaging phenotyping","volume":"21","author":"Lin","year":"2019","journal-title":"Curr Atheroscler Rep"},{"issue":"12","key":"10.1016\/j.jacl.2024.02.003_bib0017","doi-asserted-by":"crossref","first-page":"e526","DOI":"10.1093\/ehjci\/jeac174","article-title":"Pericoronary fat attenuation index-a new imaging biomarker and its diagnostic and prognostic utility: a systematic review and meta-analysis","volume":"23","author":"Sagris","year":"2022","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.jacl.2024.02.003_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215620","article-title":"HIV disease, metabolic dysfunction and atherosclerosis: a three year prospective study","volume":"14","author":"Low","year":"2019","journal-title":"PLoS One"},{"issue":"8852","key":"10.1016\/j.jacl.2024.02.003_bib0019","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/0140-6736(93)92464-5","article-title":"High plasma lipoprotein (a) in HIV-positive patients","volume":"341","author":"Constans","year":"1993","journal-title":"Lancet"},{"issue":"9","key":"10.1016\/j.jacl.2024.02.003_bib0020","first-page":"ofz301","article-title":"NOVICE study group. Elevated lipoprotein(a) in perinatally HIV-infected children compared with healthy ethnicity-matched controls","volume":"6","author":"Van den Hof","year":"2019","journal-title":"Open Forum Infect Dis"},{"issue":"10","key":"10.1016\/j.jacl.2024.02.003_bib0021","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.3390\/v13102067","article-title":"Longitudinal assessment of lipoprotein(a) levels in perinatally HIV-infected children and adolescents","volume":"13","author":"van Genderen","year":"2021","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.jacl.2024.02.003_bib0022","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5334\/gh.850","article-title":"Lipoprotein(a) and high sensitivity C-reactive protein among patients with HIV in Ghana: the study on cardiovascular risk profile of HIV-infected patients on HAART (SCRIPT)","volume":"15","author":"Appiah","year":"2020","journal-title":"Glob Heart"},{"issue":"10","key":"10.1016\/j.jacl.2024.02.003_bib0023","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1194\/jlr.P084517","article-title":"Effect of antiretroviral therapy on allele-associated Lp(a) level in women with HIV in the Women's Interagency HIV Study","volume":"59","author":"Enkhmaa","year":"2018","journal-title":"J Lipid Res"},{"issue":"7","key":"10.1016\/j.jacl.2024.02.003_bib0024","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1161\/01.CIR.100.7.700","article-title":"Atherogenic dyslipidemia in HIV-infected individuals treated with protease inhibitors. The Swiss HIV Cohort Study","volume":"100","author":"P\u00e9riard","year":"1999","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jacl.2024.02.003_bib0025","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.atherosclerosis.2012.08.010","article-title":"LDL subclasses and lipoprotein-phospholipase A2 activity in suppressed HIV-infected patients switching to raltegravir: spiral substudy","volume":"225","author":"Saumoy","year":"2012","journal-title":"Atherosclerosis"},{"issue":"10","key":"10.1016\/j.jacl.2024.02.003_bib0026","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCIMAGING.123.015693","article-title":"Rapid improvement of coronary endothelial function with PCSK9 inhibition in people with HIV is associated with reduced lipoprotein(a) and not LDL-cholesterol","volume":"16","author":"Harb","year":"2023","journal-title":"Circ Cardiovasc Imaging"},{"issue":"4","key":"10.1016\/j.jacl.2024.02.003_bib0027","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1161\/ATVBAHA.114.304785","article-title":"Race is a key variable in assigning lipoprotein(a) cutoff values for coronary heart disease risk assessment: the multi-ethnic study of atherosclerosis","volume":"35","author":"Guan","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.jacl.2024.02.003_bib0028","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/ATVBAHA.120.315291","article-title":"Lp(a) (Lipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease: new insights from a large National Biobank","volume":"41","author":"Patel","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"1","key":"10.1016\/j.jacl.2024.02.003_bib0029","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2012.113905","article-title":"Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis","volume":"309","author":"Flegal","year":"2013","journal-title":"JAMA"},{"issue":"20","key":"10.1016\/j.jacl.2024.02.003_bib0030","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.jacl.2024.02.003_bib0031","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1161\/CIRCRESAHA.115.306249","article-title":"Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, Genetics, and Biology","volume":"118","author":"Nordestgaard","year":"2016","journal-title":"Circ Res"},{"issue":"9","key":"10.1016\/j.jacl.2024.02.003_bib0032","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1172\/JCI61758","article-title":"Dynamic T cell-APC interactions sustain chronic inflammation in atherosclerosis","volume":"122","author":"Koltsova","year":"2012","journal-title":"J Clin Invest"},{"issue":"17","key":"10.1016\/j.jacl.2024.02.003_bib0033","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1016\/j.jacc.2022.08.756","article-title":"Veterans aging cohort study. Circulating T cells and cardiovascular risk in people with and without HIV infection","volume":"80","author":"Kundu","year":"2022","journal-title":"J Am Coll Cardiol"},{"issue":"7","key":"10.1016\/j.jacl.2024.02.003_bib0034","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41569-020-0352-5","article-title":"T cell subsets and functions in atherosclerosis","volume":"17","author":"Saigusa","year":"2020","journal-title":"Nat Rev Cardiol"},{"issue":"6","key":"10.1016\/j.jacl.2024.02.003_bib0035","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.14923","article-title":"REPRIEVE trial. Assessment of coronary artery disease with computed tomography angiography and inflammatory and immune activation biomarkers among adults with HIV eligible for primary cardiovascular prevention","volume":"4","author":"Hoffmann","year":"2021","journal-title":"JAMA Netw Open"},{"issue":"8","key":"10.1016\/j.jacl.2024.02.003_bib0036","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMoa2304146","article-title":"REPRIEVE investigators. Pitavastatin to prevent cardiovascular disease in HIV infection","volume":"389","author":"Grinspoon","year":"2023","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.jacl.2024.02.003_bib0037","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"JUPITER Study Group. Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.jacl.2024.02.003_bib0038","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1093\/eurheartj\/ehw024","article-title":"Residual inflammatory risk: addressing the obverse side of the atherosclerosis prevention coin","volume":"37","author":"Ridker","year":"2016","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.jacl.2024.02.003_bib0039","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/jama.2023.16503","article-title":"Muvalaplin, an oral small molecule inhibitor of lipoprotein(a) formation: a randomized clinical trial","volume":"330","author":"Nicholls","year":"2023","journal-title":"JAMA"},{"issue":"17","key":"10.1016\/j.jacl.2024.02.003_bib0040","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jama.2022.5050","article-title":"Single ascending dose study of a short interfering RNA targeting lipoprotein(a) production in individuals with elevated plasma lipoprotein(a) levels","volume":"327","author":"Nissen","year":"2022","journal-title":"JAMA"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424000242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424000242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,29]],"date-time":"2024-12-29T23:13:22Z","timestamp":1735514002000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287424000242"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S1933287424000242"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2024.02.003","relation":{},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of Lipoprotein(a) with peri-coronary inflammation in persons with and without HIV infection","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2024.02.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 National Lipid Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}